Can you break down the clinical trial data regarding lemborexant for sleep maintenance insomnia in adults over the age of fifty?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Can you break down the clinical trial data regarding lemborexant for sleep maintenance insomnia in adults over the age of fifty?
3 real searches · 1 real-search pass
lemborexant SUNRISE 1 trial older adults 55 years sleep maintenance insomnia results wake after sleep onset total sleep time 2019Google ↗
OBSERVED
lemborexant SUNRISE 2 trial sleep maintenance insomnia adults efficacy 6 months resultsGoogle ↗
OBSERVED
DAYVIGO prescribing information elderly trial sleep maintenance insomnia adverse reactions falls somnolenceGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
lemborexant SUNRISE 1 trial older adults 55 years sleep maintenance insomnia results wake after sleep onset total sleep time 2019 Google ↗
lemborexant SUNRISE 2 trial sleep maintenance insomnia adults efficacy 6 months results Google ↗
DAYVIGO prescribing information elderly trial sleep maintenance insomnia adverse reactions falls somnolence Google ↗
- Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial · pmc.ncbi.nlm.nih.gov
- EFFICACY OF LEMBOREXANT COMPARED WITH ZOLPIDEM EXTENDED RELEASE AND PLACEBO IN ELDERLY SUBJECTS WITH INSOMNIA: RESULTS FROM A PHASE 3 STUDY (SUNRISE 1) · sciencedirect.com
- Efficacy and Safety of Lemborexant vs Zolpidem Extended Release and Placebo in Elderly Subjects with Insomnia: Results from SUNRISE-1 (1868) · neurology.org
- Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2 · pmc.ncbi.nlm.nih.gov
- Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2 · pubmed.ncbi.nlm.nih.gov
- Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial · pubmed.ncbi.nlm.nih.gov
- These highlights do not include all the information needed to use DAYVIGO ® safely and effectively. See full prescribing information for DAYVIGO ® . DAYVIGO ® (lemborexant) tablets, for oral use, CIV Initial U.S. Approval: 2019 · dailymed.awsprod.nlm.nih.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
lemborexant SUNRISE 1 trial older adults 55 years sleep maintenance insomnia results wake after sleep onset total sleep time 2019 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
lemborexant SUNRISE 2 trial sleep maintenance insomnia adults efficacy 6 months results OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
DAYVIGO prescribing information elderly trial sleep maintenance insomnia adverse reactions falls somnolence OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |